1. FACT/JACIE Standards, 4th edn. International Standards for Cellular Therapy Product Collection, Processing and Administration. Available from website of Joint Accreditation Committee of ISCT and EBMT (JACIE), at http://www.jacie.org/portal/en/public/documentcentre . Accessed 1 November 2011
2. Szczepiorkowski ZM, Shaz BH, Bandarenko N, Winters JL (2007) The new approach to assignment of ASFA categories—introduction to the fourth special issue: clinical applications of therapeutic apheresis. J Clin Apher 22:96–105
3. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH (2010) Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 25:83–177
4. Cooling L, Hoffmann S, Herrst M, Muck C, Armelagos H, Davenport R (2010) A prospective randomized trial of two popular mononuclear cell collection sets for autologous peripheral blood stem cell collection in multiple myeloma. Transfusion 50:100–119
5. Tanhehco YC, Adamski J, Sell M, Cunningham K, Eisenmann C, Magee D, Stadtmauer EA, O’Doherty U (2010) Plerixafor mobilization leads to a lower ratio of CD34+ cells to total nucleated cells which results in greater storage costs. J Clin Apher 25(4):202–208